Thursday, April 30, 2026 | 02:55 AM ISTहिंदी में पढें
Marksans Pharma Ltd
Announcement under Regulation 30 (LODR)-Press Release / Media Release
09:12 AM, 19th Jun 2025
Marksans Pharma Limiteds wholly owned subsidiary in the UK Relonchem Limited received Marketing Authorisation for its product Oxybutynin Hydrochloride 2.5mg/5ml oral solution from UK MHRA